The Providers Clinical Support System – Medications for Opioid Use Disorder (PCSS-MOUD) is comprised of a coalition of major healthcare organizations dedicated to addressing the opioid overdose crisis. PCSS's mission is to increase healthcare providers' knowledge and skills in the prevention, identification and treatment of substance use disorders with a focus on opioid use disorders.
Learn more at PCSSnow.org.
Funding for this initiative was made possible by cooperative agreement No. 1H79TI086770 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
About PCSS-MOUD
The Providers Clinical Support System for Medications for Opioid Use Disorders (PCSS-MOUD) is a program funded by the Substance Abuse and Mental Health Services Administration (SAMHSA). It is led by the American Academy of Addiction Psychiatry (AAAP) in collaboration with a wide coalition of national professional and healthcare organizations. PCSS-MOUD aims to increase the knowledge and skills of healthcare and counseling professionals about available evidence-based treatment approaches for substance use disorder (SUD) with a particular focus on opioid use disorder (OUD). PCSS-MOUD provides free training and mentoring to practitioners on the use of medications for OUD (MOUD) and the integration of these services into mainstream health care.